In Focus
Updating the guidelines for RFID in transfusion medicine
The benefits of using Radio Frequency Identification (RFID) technology
With aging populations in many countries, the supply of donated blood is dropping while demand is increasing. Reducing unnecessary wastage is a challenge and important goal for blood administrators.
Radio Frequency Identification (RFID) technology provides real-time visibility of all units in storage and real-time visibility of all movements including who actioned them when linked with the storage device access control.
This visibility is completely independent of the user following any proper procedures and enables complete End to End traceability with a full audit trail, cold chain record-keeping, compliance and automated compliance enforcement at all times.
RFID has the potential to eliminate wastage and avoidable human errors in blood transfusion.
Background
In 2006 the International Society for Blood Transfusion Working Party on Information Technology (ISBT WPIT) voted to create a Task Force on RFID to review the current state of RFID development and recommend guidelines for the use of RFID in transfusion medicine. Four years later in 2010, the Guidelines for Use of RFID in Transfusion Medicine were published in Vox Sanguinis. Since the publication of the 2010 Guidelines there have been significant advances in the available RFID technology including the development of equipment integrated RFID readers installed into fridges, freezers, agitators, incubators, cold room shelving and freezer room shelving. RFID integrated storage equipment can provide real time visibility with unattended and automated stocktaking and location tracking of blood products in storage. Real time temperature logs of all stored products can be automatically generated ensuring a record of cold chain compliance for all stored products. The real-time visibility provided by RFID can eliminate wastage through mishandling with automated error messaging and compliance enforcement.
Advantages of RFID
Printed barcodes remain the most widely used AIDC system to identify units in blood processing systems. Manual and barcode systems require user action to record or scan units and only provide a snapshot of the units in storage at the time the units are being handled or scanned. In contrast RFID can provide a continuous record of unit location information and temperature providing a guaranteed record of compliance for complete End to End traceability—from donation to transfusion with a full audit trail, cold chain record-keeping and compliance knowing the real time location of each blood unit in storage and movements into and out of storage from the point of donation right up to transfusion into the patient. RFID can support the quick and easy access to process data generated in the blood supply chain, including collection, manufacturing, testing, release labelling, inventory, and distribution. With the appropriate software, inventory checks can be performed remotely and without attending the storage location for a full picture in seconds from the administrator’s desk, for real End to End visibility from donation to transfusion. During the distribution process, bulk packaging could be checked for completeness on dispatch and receipt using tunnel readers allowing the transmission of shipment information to be done rapidly using the RFID label with no need for line-of-sight for scanning, which makes it easy for employees to perform concurrent manual activities. Hospitals may provide the greatest and most immediate benefits from RFID in transfusion medicine. Implementing RFID at hospitals with RFID fitted fridges, freezers and agitators or incubators has the potential to deliver processing time savings for staff and cold chain compliance through automated enforcement of handling procedures and rules, reducing wastage through real time visibility and an electronic audit record of all movements. The guarantee that all units have been correctly stored and handled can allow for units to be safely moved between hospitals to enable distributed blood, plasma and platelet banking on a city, state, or country wide basis. Studies have shown that moving blood between hospitals can eliminate expiry wastage by matching blood units to the local patient demand across a group of hospitals. By integrating RFID into other transfusion equipment there is the possibility to further improve processes. For example, at the point of collection, an RFID reader integrated into the blood collector could record the donation timing and record the weight of a blood donation. Similarly integrating an RFID reader into a transfusion stand would record the instant the transfusion starts and stops and track the correct placement and administration of a unit of blood at the point of transfusion. RFID enabled devices can remove the reliance on operators taking specific activities and records to provide real time visibility of operations.
Transplantation Medicine
In transplantation medicine, RFID can support the quick and easy access to process and product data for cellular therapy products, tissues, organs, and other medical products of human origin. These products require rapid freezing after harvesting prior to long term storage at ULT. For existing paper-based data carriers these conditions of preparation and storage present challenges of data entry and accuracy and rely on manual methods for tracking and product selection. Transplantation products are also moved out of their source location between cities, states and even countries. RFID labels allow remote non-contact accurate data entry and real time tracking and product location. RFID readers can be installed into ULT freezers for communication with RFID labels applied at the time of harvesting prior to rapid freezing. Process and product data can be retrieved or modified, and products automatically monitored and tracked in real time whilst fully ULT frozen and without disturbing or handling the products.
Remote Blood Management
The management of remote emergency fridge stocks presents challenges in ensuring the safety of stock, adequacy of stock levels and timely restocking. RFID fitted remote emergency fridges can provide automated remote real time visibility of fridge stocks including blood components and batch products allowing for cold chain monitoring and timely restocking. This ability to automate the real time visibility of remote stocks results in the ability to automate cold chain record keeping, the timestamping of unit placement and removal, the collection of recipient data and the ability to automatically generate alerts when automation rules are breached.
Patient Safety
RFID provides real-time visibility of all units in storage and real-time visibility of all movements including who actioned them when linked with the storage device access control. This visibility is completely independent of the user following any proper procedures. Units moved out of storage incorrectly are instantly identified with an RFID system and the user can be instantly notified. If no suitable rectification is made, then automated alerts can be sent up the chain to laboratory and blood bank staff. If units are incorrectly handled, the RFID system enables corrective action to be taken before a serious medical incident. In particular, RFID can eliminate the processing, tracking and administration errors in transfusion defined in Serious Hazards of Transfusion (SHOT) reports. These include Near miss, Anti-D immunoglobin errors, Incorrect blood component transfusion, Handling and storage errors, Right blood right patient, Avoidable transfusion, Delayed transfusion and Over or Under transfusion. These events account for more than 80% of all (SHOT) incidents with the remaining related to adverse medical reactions or complications.
Summary
In 2022 the WPIT decided to update the 2010 RFID guidelines in line with the advances in RFID technology pertinent to transfusion medicine. The update is being written for all those who are interested in using RFID in transfusion medicine, including batch products, autologous blood donations and cell salvage, and cellular therapy products, tissues, organs, and other medical products of human origin (MPHO). This Guideline update builds on the prior version and will be focusing on the changes since the 2010 publication. The WPIT is engaging with clinical leaders in the transfusion medicine working with RFID and welcomes the support of ISBT members interested in joining the WPIT and participate in drafting the Guideline update.